Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
Enrolling by invitation · NCT05897957 · Registry updated 2024-04-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 | Nutritional and Metabolic Diseases, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, synucleinopathy | Enrolling by invitation | Not stated | 2024-04-12 | NCT05897957 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BlueRock Therapeutics | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Toronto Western Hospital | Toronto | Canada | 44 |
| University of California, Irvine | Orange | United States | 29 |
| Weill Cornell Medical College | New York | United States | 58 |